| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910524871703321 |
|
|
Autore |
Connolly Cynthia A |
|
|
Titolo |
Children and Drug Safety : Balancing Risk and Protection in Twentieth-Century America / / Cynthia A Connolly |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New Brunswick, NJ : , : Rutgers University Press, , [2018] |
|
©2018 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Descrizione fisica |
|
|
|
|
|
|
Collana |
|
Critical Issues in Health and Medicine |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
History, 20th Century |
Health Policy - history |
Drug and Narcotic Control - history |
Drug Therapy - standards |
Child |
Drug Therapy - history |
Electronic books. |
United States |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Frontmatter -- Contents -- 1. Drug Therapy: From "Baby Killers" to Baby Savers, 1906-1933 -- 2. New Drugs, Old Problems in Pediatrics: From Therapeutic Nihilism to the Antibiotic Era, 1933-1945 -- 3. The Child as Drug Development Problem and Business Opportunity in a New Era, 1945-1961 -- 4. The Growth and Development of the Therapeutic Orphan, 1961-1979 -- 5. A "Big Business Built for Little Customers": Candy Aspirin, Children, and Poisoning, 1947-1976 -- 6. Children and Psychopharmacology in Postwar America -- 7. Pediatric Drug Development and Policy after 1979 -- Appendix -- Acknowledgments -- Notes -- Index -- About the Author |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
Children and Drug Safety traces the development, use, and marketing of drugs for children in the twentieth century, a history that sits at the interface of the state, business, health care providers, parents, and children. This book illuminates the historical dimension of a clinical and policy issue with great contemporary significance-many of the drugs |
|
|
|
|
|
|
|
|
|
|
administered to children today have never been tested for safety and efficacy in the pediatric population. Each chapter of Children and Drug Safety engages with major turning points in pediatric drug development; themes of children's risk, rights, protection and the evolving context of childhood; child-rearing; and family life in ways freighted with nuances of race, class, and gender. Cynthia A. Connolly charts the numerous attempts by Congress, the Food and Drug Administration, the American Academy of Pediatrics, and leading pediatric pharmacologists, scientists, clinicians, and parents to address a situation that all found untenable. |
|
|
|
|
|
| |